This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Padilla, E.
Right arrow Articles by Albertí, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Padilla, E.
Right arrow Articles by Albertí, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2010, p. 177-183, Vol. 54, No. 1
0066-4804/10/$12.00+0     doi:10.1128/AAC.00715-09
Copyright © 2010, American Society for Microbiology. All Rights Reserved.

Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence{triangledown}

Emma Padilla,1 Enrique Llobet,2 Antonio Doménech-Sánchez,1 Luis Martínez-Martínez,3 José Antonio Bengoechea,2,4 and Sebastián Albertí1*

Institut Universitari d'Investigacions en Ciències de la Salut (IUNICS) and Departament de Biologia, Universitat de les Illes Balears (UIB), Palma de Mallorca, Spain,1 Fundación Caubet-CIMERA Illes Balears and Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Bunyola, Spain,2 Servicio de Microbiología, Hospital Universitario Marques de Valdecilla, and Departmento de Biología Molecular, Universidad de Cantabria, Santander, Spain,3 Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain4

Received 27 May 2009/ Returned for modification 7 July 2009/ Accepted 20 October 2009

Respiratory infections caused by Klebsiella pneumoniae are characterized by high rates of mortality and morbidity. Management of these infections is often difficult, due to the high frequency of strains that are resistant to multiple antimicrobial agents. Multidrug efflux pumps play a major role as a mechanism of antimicrobial resistance in Gram-negative pathogens. In the present study, we investigated the role of the K. pneumoniae AcrRAB operon in antimicrobial resistance and virulence by using isogenic knockouts deficient in the AcrB component and the AcrR repressor, both derived from the virulent strain 52145R. We demonstrated that the AcrB knockout was more susceptible, not only to quinolones, but also to other antimicrobial agents, including β-lactams, than the wild-type strain and the AcrR knockout. We further showed that the AcrB knockout was more susceptible to antimicrobial agents present in human bronchoalveolar lavage fluid and to human antimicrobial peptides than the wild-type strain and the AcrR knockout. Finally, the AcrB knockout exhibited a reduced capacity to cause pneumonia in a murine model, in contrast to the wild-type strain. The results of this study suggest that, in addition to contributing to the multidrug resistance phenotype, the AcrAB efflux pump may represent a novel virulence factor required for K. pneumoniae to resist innate immune defense mechanisms of the lung, thus facilitating the onset of pneumonia.


* Corresponding author. Mailing address: Universitat de les Illes Balears, Edificio Científico-técnico, CAMPUS-UIB, Crtra. Valldemosa, km 7.5, Palma de Mallorca 07122, Spain. Phone: 34-971-173353. Fax: 34-971-259501. E-mail: sebastian.alberti{at}uib.es

{triangledown} Published ahead of print on 26 October 2009.


Antimicrobial Agents and Chemotherapy, January 2010, p. 177-183, Vol. 54, No. 1
0066-4804/10/$12.00+0     doi:10.1128/AAC.00715-09
Copyright © 2010, American Society for Microbiology. All Rights Reserved.